CeriBell, Inc.

NASDAQ:CBLL

Medical - Devices

Healthcare
$25.63 +1.42%

+$0.25 today

Market cap
$995.34M
Beta
0.84
P/E (TTM)
-10.9
EPS (TTM)
-$1.60
52W Low $10.85High $24.33

Volume 0.41M

Average 0.29M

CBLL Income Before Tax

Profit after all operating and non-operating items but before income tax.

CeriBell, Inc.NASDAQ: CBLL

Income Before Tax · Q1 FY2026 · quarter ended Mar 2026

Income before tax remains negative

Q1 FY2026 income before tax was -$19.74M, compared with -$12.78M a year earlier. Trailing-twelve-month income before tax was -$60.37M.

Context

  • Income before tax amounted to 60.0% of revenue in FY2025, down 1.8 pp from a year earlier.
  • Income before tax grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly income before tax holds near -$19.74M or moves back toward the trailing-twelve-month quarterly average of -$15.09M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$19.74M-45.9% QoQ
Last fiscal yearDec 2025
-$53.41M-32.0% YoY
LTMMar 2026
-$60.37M-35.7% YoY
Income Before Tax past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-54.5%——
1 year-32.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Before Tax history

USD · from the income statement

Latest · FY2025
(53.41M) USD
Year-over-year change
-32.0%

Income Before Tax vs competitors

How CBLL compares with its peers on the latest reported figures

  • CBLL's LTM Mar 2026 income before tax of -$60.37M is the lowest of the 7 companies compared; the peer median is -$18.61M.
  • Its year-over-year change of -35.7% is the lowest of 7, against a peer median of +18.2%.
  • Income before tax amounts to 63.5% of revenue for CBLL, versus a peer median of 23.1%.
CBLL Competitors Peer median
Income Before Tax for CBLL and competitors
Company Period LTM YoY 3-year CAGR% of revenue
LIVNLivaNova PLCLTM Sep 2026$119.59M +162.3%—7.9%
BWAYBrainsWay Ltd.LTM Mar 2026$8.86M +99.5%—15.8%
ECORelectroCore, Inc.LTM Mar 2026-$15.65M -27.7%—44.9%
NPCENeuroPace, Inc.LTM Mar 2026-$21.57M +13.1%—21.7%
STIMNeuronetics, Inc.LTM Mar 2026-$37.25M +23.3%—24.6%
CVRXCVRx, Inc.LTM Mar 2026-$52.67M -2.2%—89.2%
CBLLCeriBell, Inc.LTM Mar 2026-$60.37M -35.7%—63.5%
Peer median (excluding CBLL) -$18.61M+18.2%—23.1%

Competitors are the stored peer set for CBLL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue25.92M45.23M65.44M89.06M
Cost of Revenue4.43M7.06M8.69M10.79M
Gross Profit21.49M38.16M56.75M78.27M
Gross Margin82.9%84.4%86.7%87.9%
Research & Development7.24M9M13.56M19.14M
Selling, General & Admin50.27M59.21M82.9M117.53M
Operating Expenses57.51M68.2M96.46M136.68M
Depreciation & Amortization497K847K1.14M1.34M
EBITDA(35.06M)(26.51M)(37.32M)(50.18M)
EBITDA Margin-135.3%-58.6%-57.0%-56.3%
Operating Income(36.02M)(30.04M)(39.71M)(58.4M)
Operating Margin-139.0%-66.4%-60.7%-65.6%
Interest Income0000
Interest Expense1.6M2.1M1.99M1.89M
Other Income / Expenses(1.14M)588K(746K)4.99M
Income Before Tax(37.16M)(29.45M)(40.46M)(53.41M)
Pre-Tax Margin-143.4%-65.1%-61.8%-60.0%
Income Tax Expense2K11K00
Net Income(37.16M)(29.46M)(40.46M)(53.41M)
Net Margin-143.4%-65.1%-61.8%-60.0%
EPS (Basic)(1.59)(1.26)(3.39)(1.46)
EPS (Diluted)(1.59)(1.26)(3.39)(1.46)
Weighted Avg Shares23.32M23.32M11.95M36.54M
Weighted Avg Shares (Diluted)23.32M23.32M11.95M36.54M

CeriBell, Inc.

NASDAQ:CBLL

Intrinsic Alpha fair value

Locked

Current Price

$25.63

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.